<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362357">
  <stage>Registered</stage>
  <submitdate>10/04/2012</submitdate>
  <approvaldate>19/04/2012</approvaldate>
  <actrnumber>ACTRN12612000445875</actrnumber>
  <trial_identification>
    <studytitle>Beetroot juice lowers blood pressure</studytitle>
    <scientifictitle>The effect of beetroot juice on lowering blood pressure in free-living individuals</scientifictitle>
    <utrn>U1111-1129-8711</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Hypertension</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Hypertension</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The study was designed as a randomised, placebo controlled cross-over study with a 2 week washout period.  Volunteers consumed a single dose of 500g of Sunraysia Beetroot and Apple Juice in the institute clinic over 5 - 10 minutes.  Systolic / diastolic blood pressure and pulse rate was then monitored over the following 24 hours using an ambulatory blood pressure monitor.  Volunteers were asked to avoid moderate or vigorous physical activity on the day of the trial, but no other restrictions, such as diet, were required of volunteers, either on intervention days or during the washout period.</interventions>
    <comparator>500g of placebo juice consisting of apple juice concentrate base matched to the beetroot &amp; apple juice for sweetness (sucrose) and colour (carmine red and rubini red)</comparator>
    <control>Placebo</control>
    <interventioncode>Lifestyle</interventioncode>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in systolic blood pressure relative to control using an ambulatory blood pressure monitor.</outcome>
      <timepoint>At any given time point within 24 hours after consuming the beetroot and apple juice</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Change in diastolic blood pressure relative to control using an ambulatory blood pressure monitor.</outcome>
      <timepoint>At any given time point within 24 hours after consuming the beetroot and apple juice</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in pulse pressure relative to control using an ambulatory blood pressure monitor.</outcome>
      <timepoint>At any given time point within 24 hours after consuming the beetroot and apple juice</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Resting baseline systolic blood pressure greater than 120 mmHg on first day of treatment.  No upper limit on systolic blood pressure - hypertensive subjects also eligible</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Pregnant
Lactating
Diabetes
On blood pressure medication</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Both the researcher who determiend if the subject was eligible for inclusion in the trial, and the subject, we not aware if the subject would be allocated to the treatment or the placebo first. Allocation was centrally performed by computer software.</concealment>
    <sequence>Simple randomisation by computer software (i.e. computerised sequence generation)</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>9/12/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Charities/Societies/Foundations</primarysponsortype>
    <primarysponsorname>Baker IDI Heart &amp; Diabetes Institute</primarysponsorname>
    <primarysponsoraddress>75 Commercial Rd
Prahran 
VIC 3181</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>The Sunraysia Natural Beverage Company</fundingname>
      <fundingaddress>121 Cecil Street South 
Melbourne 
VIC 3205</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The trial aims to assess the potential benefit of consuming beetroot juice as part of a normal diet with regard to lowering blood pressure in normotensive, free-living individuals.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Alfred human Research Ethics Committee</ethicname>
      <ethicaddress>Ground Floor, Linay Pavilion, 
The Alfred Hospital, 
Commercial Road,
Melbourne. 
VIC 3004.</ethicaddress>
      <ethicapprovaldate>26/09/2011</ethicapprovaldate>
      <hrec>Approval number 377/11</hrec>
      <ethicsubmitdate>20/09/2011</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Prof Peter Clifton</name>
      <address>GPO Box 664 Adelaide SA 5001</address>
      <phone>+61884629702</phone>
      <fax />
      <email>peter.clifton@bakeridi.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof Peter Clifton</name>
      <address>GPO Box 664 Adelaide SA 5001</address>
      <phone>+61884629702</phone>
      <fax />
      <email>peter.clifton@bakeridi.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Leah Coles</name>
      <address>Baker IDI Heart &amp; Diabetes Institute
Level 4
99 Commercial Rd
Prahran
VIC 3181</address>
      <phone>+61385321855</phone>
      <fax />
      <email>leah.coles@bakeridi.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>